Multiple Sclerosis Prevention


Multiple Sclerosis Prevention: Try Multiple Sclerosis prevention with information & solutions on lifestyle changes and taking vitamin supplements.

While some studies dispute it, there is preliminary evidence that exposure to organic solvents, insecticides, and X-rays may cause or aggravate MS. This may explain why clusters of multiple sclerosis cases occasionally occur in certain geographical areas or even in work sites.


Swiss researchers found that nicotine temporarily impairs arm movement in people with MS. In one study, when people with MS smoked cigarettes, movement capacity was diminished for 10 minutes in 76% of them. Although this evidence is preliminary, there are many other adverse health effects of smoking. Smokers with MS should quit smoking.


While the outcome of some research disputes the connection between MS and mercury exposure, other investigations have reported an association between dental amalgams and this disease. One study found that mercury levels in the hair of people with MS are higher than in the hair of healthy people. This same report found that people with MS who had their amalgam fillings removed experienced one-third fewer relapses than people who kept their fillings. Another preliminary study found that people having a large number of fillings that had been in place for a long time appeared to be at increased risk for MS compared with those having fewer fillings. Preliminary evidence has also identified an association between tooth decay—as opposed to fillings—and MS. The importance of the reported links between mercury, tooth decay, and risk of MS has not been clearly established.


This information is not intended to replace your doctor's advice. See Full Article, Click Here

Dr Balch's Vitamin Formula for Multiple Sclerosis

Formulas form 35 Years of Medical Practice
Serving Size:3
For more information regarding Vitamins & Nuatural Supplements for Multiple Sclerosis Prevention,click here
Supplement Facts
Specially Formulated for: Multiple Sclerosis
  • Amount Per Serving
    % DV
    Vitamin C
    200
    mg
    333%
    Vitamin E
    200
    IU
    667%
    Thiamin
    50
    mg
    3333%
    Riboflavin
    50
    mg
    2941%
    Niacin
    50
    mg
    250%
    Vitamin B6
    50
    mg
    2500%
    Folate
    800
    mcg
    200%
    Vitamin B12
    550
    mcg
    9167%
    Biotin
    50
    mcg
    17%
    Pantothenic Acid
    50
    mg
    500%
  • Amount Per Serving
    % DV
    Zinc
    10
    mg
    67%
    Copper
    1
    mg
    50%
    Choline Bitartrate
    50
    mg
    *
    Inositol
    50
    mg
    *
    PABA
    50
    mg
    *
    Flax Seed Powder
    50
    mg
    *
    Ginkgo Extract
    80
    mg
    *
    N-Acetyl L-Cysteine
    500
    mg
    *
    * Daily Value (DV) not established
Customize it
Add to Cart
Latest Health Related News:
CHMP Recommends Approval Of Olanzapine Long-acting Injection For Maintenance Treatment Of Schizophrenia In Europe
The Committee for Medicinal Products for Human Use (CHMP) has recommended European approval of Olanzapine Long-acting Injection (LAI), known in Europe by the trade name Zypadhera(TM), for maintenance treatment of adult patients with schizophrenia sufficiently stabilized during acute treatment with oral olanzapine, Eli Lilly and Company (LLY) announced today.
Autism Research Benefits From Author Royalties Donated Following Publication Of Autism Book
Paul Offit, M.D., has announced that all author royalties earned from the sale of his new book, "Autism's False Prophets: Bad Science, Risky Medicine, and the Search for a Cure," will be donated to the Center for Autism Research at Children's Hospital of Philadelphia. "We are very pleased to partner with Dr. Offit, and to accept the royalties of his book for the work done here at the Center for Autism Research (CAR) at Children's Hospital of Philadelphia," said Dr.
Orphan Drug Designation For ALD-10, Novel Stem Cell Therapy For Patients With Metabolic Disorders Undergoing Umbilical Cord Blood Transplantation
Aldagen, Inc. today announced that it has received orphan drug designation for ALD-101 from the U.S. Food and Drug Administration (FDA). The designation was granted for the use of ALD-101 to improve patient outcomes by decreasing time to platelet and neutrophil engraftment in patients with inherited metabolic disorders undergoing umbilical cord blood transplantation.
This information concerning the Multiple Sclerosis Prevention provides basic knowledge which should always be discussed with your own health practitioner. Multiple Sclerosis Prevention, Management, Support, Solution, Control.
Any Questions, Call Us Toll Free: 1-866-585-1390
Mitamins Logo

Multiple Sclerosis Prevention

Home  Conditions Info  Multiple Sclerosis  Multiple Sclerosis Prevention
Live Chat System


Dr. James Balch's Natural Prescription Inside
manufactured In USA

  verisign          Trust E Finalmark

Multiple Sclerosis Prevention with Custom Vitamins & Nutritional Supplements